Clinical Trial Update: Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on intramuscular rAAV1.CMV.huFollistatin344 for Duchenne muscular dystrophy completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• rAAV1.CMV.huFollistatin344 (follistatin-344 gene therapy)

Snippet

Sponsor: Jerry R. Mendell | Conditions: Duchenne Muscular Dystrophy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-04-15